| Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo S Venneti, MP Dunphy, H Zhang, KL Pitter, P Zanzonico, C Campos, ... Science translational medicine 7 (274), 274ra17-274ra17, 2015 | 307 | 2015 |
| A pretargeted PET imaging strategy based on bioorthogonal Diels–Alder click chemistry BM Zeglis, KK Sevak, T Reiner, P Mohindra, SD Carlin, P Zanzonico, ... Journal of Nuclear Medicine 54 (8), 1389-1396, 2013 | 306 | 2013 |
| Dependence of FDG uptake on tumor microenvironment A Pugachev, S Ruan, S Carlin, SM Larson, J Campa, CC Ling, JL Humm International Journal of Radiation Oncology* Biology* Physics 62 (2), 545-553, 2005 | 205 | 2005 |
| Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system C Heneweer, JP Holland, V Divilov, S Carlin, JS Lewis Journal of Nuclear Medicine 52 (4), 625-633, 2011 | 189 | 2011 |
| Real-time imaging of HIF-1α stabilization and degradation E Moroz, S Carlin, K Dyomina, S Burke, HT Thaler, R Blasberg, ... PloS one 4 (4), e5077, 2009 | 152 | 2009 |
| Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor … HJ Cho, E Ackerstaff, S Carlin, ME Lupu, Y Wang, A Rizwan, ... Neoplasia 11 (3), 247-IN3, 2009 | 141 | 2009 |
| Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy XF Li, S Carlin, M Urano, J Russell, CC Ling, JA O'Donoghue Cancer research 67 (16), 7646-7653, 2007 | 134 | 2007 |
| A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers S Carlin, H Zhang, M Reese, NN Ramos, Q Chen, SA Ricketts Journal of Nuclear Medicine 55 (3), 515-521, 2014 | 127 | 2014 |
| Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex A Riad, C Zeng, CC Weng, H Winters, K Xu, M Makvandi, T Metz, S Carlin, ... Scientific reports 8 (1), 16845, 2018 | 112 | 2018 |
| Optimization of a pretargeted strategy for the PET imaging of colorectal carcinoma via the modulation of radioligand pharmacokinetics BM Zeglis, C Brand, D Abdel-Atti, KE Carnazza, BE Cook, S Carlin, ... Molecular pharmaceutics 12 (10), 3575-3587, 2015 | 111 | 2015 |
| Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET YY Janjigian, N Viola-Villegas, JP Holland, V Divilov, SD Carlin, ... Journal of Nuclear Medicine 54 (6), 936-943, 2013 | 107 | 2013 |
| 89Zr-Labeled Paramagnetic Octreotide-Liposomes for PET-MR Imaging of Cancer DS Abou, DLJ Thorek, NN Ramos, MWH Pinkse, HT Wolterbeek, ... Pharmaceutical research 30, 878-888, 2013 | 107 | 2013 |
| Noninvasive interrogation of DLL3 expression in metastatic small cell lung cancer SK Sharma, J Pourat, D Abdel-Atti, SD Carlin, A Piersigilli, AJ Bankovich, ... Cancer research 77 (14), 3931-3941, 2017 | 103 | 2017 |
| PET of hypoxia: current and future perspectives S Carlin, JL Humm Journal of Nuclear Medicine 53 (8), 1171-1174, 2012 | 98 | 2012 |
| Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry JL Houghton, R Membreno, D Abdel-Atti, KM Cunanan, S Carlin, ... Molecular cancer therapeutics 16 (1), 124-133, 2017 | 97 | 2017 |
| Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives NT Viola-Villegas, KK Sevak, SD Carlin, MG Doran, HW Evans, ... Molecular pharmaceutics 11 (11), 3965-3973, 2014 | 89 | 2014 |
| Mapping tumor hypoxia in vivo using pattern recognition of dynamic contrast-enhanced MRI data R Stoyanova, K Huang, K Sandler, HJ Cho, S Carlin, PB Zanzonico, ... Translational oncology 5 (6), 437-IN2, 2012 | 87 | 2012 |
| Efficient 18F-Labeling of Large 37-Amino-Acid pHLIP Peptide Analogues and Their Biological Evaluation P Daumar, CA Wanger-Baumann, NVK Pillarsetty, L Fabrizio, SD Carlin, ... Bioconjugate chemistry 23 (8), 1557-1566, 2012 | 83 | 2012 |
| Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models S Carlin, SH Cunningham, M Boyd, AG McCluskey, RJ Mairs Cancer gene therapy 7 (12), 1529-1536, 2000 | 83 | 2000 |
| Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging BM Zeglis, CB Davis, D Abdel-Atti, SD Carlin, A Chen, R Aggeler, ... Bioconjugate Chemistry 25 (12), 2123-2128, 2014 | 82 | 2014 |
Jason S. LewisMSKCCBestätigte E-Mail-Adresse bei mskcc.org
